Multiple Myeloma (MM) is a type of blood cancer. When it affects the kidneys, it's called RIMM (myeloma with renal impairment). This study is exploring if early treatment can help the kidneys work better and if a special procedure called autoHSCT (autologous hematopoietic stem cell transplantation) can further help. AutoHSCT is like a "reset" for the body using the person's own cells.
The study is trying to find out if using treatments early can help people with kidney problems due to myeloma. Some of the new treatments use special medicines that target cancer cells more precisely. Doctors will use medicines called proteasome inhibitors and immunomodulators to see how well they work in keeping the kidneys healthy.
NCT06203145
Peking University First Hospital
24 January 2024
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Congrats! You have your own personal workspace now.